Corrupted tensional homeostasis accompanies tumor progression.

Slides:



Advertisements
Similar presentations
Metastasis. Mechanisms of Invasion and Metastasis.
Advertisements

Ability to Invade and Metastasize The spread of tumors is a complex process involving a series of sequential steps, may be interrupted at any stage by.
The Microenvironment, Stem Cells, and Cancer. Microenvironment Signaling molecules – G-CSF – Erythropoietin Cell-cell contact – Adherens junctions – Gap.
Tumor genetics Minna Thullberg
Cancer Deregulation of cell cycle Loss of control of mitosis Result of mutation Over 200 types of cancer exists (Number of cancer cases will double by.
Oncogenes, Tumor Suppressors, and the Cell Cycle Radiobiology 2012.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
A schematic comparison is shown of the highly coordinated and quantitatively regulated hierarchy of normal tissue populations in which cell turnover is.
Regulation of Gene Expression. You Must Know The functions of the three parts of an operon. The role of repressor genes in operons. The impact of DNA.
CANCER. General A general grouping of all diseases related to unregulated cell growth Cancers generally develop by an accumulation of mutations of the.
Mutational analysis of 35 bladder cancer cell lines using RNA-seq.
Benign Versus Malignant Tumors
Chapter 6 Cancer. Frequency and Significance Cancer is the 2 nd leading cause of death in the United States Obviously, the term cancer covers many types.
Fun Fact! There are over 200 different types of cells in the human body, each performing specific functions!
Cancer Bioinformatics Tom Doman Bioinformatics Scientist Eli Lilly & Company Informatics 519 guest lecture IU Bloomington Sept
Development, Stem Cells, and Cancer
Mouse Double Minute 2 (MDM2)
Cancer – a disease of many mutations
p53 function and regulation in normal cells and cancer cells
The Genetic Basis of Cancer
Strategies for differential inhibition of mTORC1 and mTORC2 with rapamycin. Strategies for differential inhibition of mTORC1 and mTORC2 with rapamycin.
EBV DNA: a Hodgkin lymphoma biomarker?
Cancer Biology Jasmina Makarevic
IL-22 Gets to the Stem of Colorectal Cancer
Fibroblast Growth Factor 3 (FGF3) int-2
Molecular Basis Of Cancer
Inflammation and Colon Cancer
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Notch1 and its role in pre-T-cell acute lymphoblastic leukemia (T-ALL)
Extracellular Regulation of Apoptosis
Breast Cancer Bone Metastases: It’s All about the Neighborhood
BIOLOGY 12 Cancer.
Cell tension, matrix mechanics, and cancer development
Mechanisms of Hepatic Fibrogenesis
Biology and Clinical Applications of Pancreatic Cancer Stem Cells
Cancer.
Cancer Metastasis: Building a Framework
Hallmarks of Cancer: The Next Generation
Figure 4 Podocyte–endothelial cross talk and activation of heparanase
Mechanisms of PARPi resistance in HR-deficient cells.
Volume 146, Issue 5, Pages (May 2014)
Rushika M. Perera, Nabeel Bardeesy  Cancer Cell 
The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial- Mesenchymal Barrier  Roni Nowarski, Ruaidhrí Jackson, Richard A. Flavell 
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Cellular signalling: Stressing the importance of PIP3
ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities  Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander.
Tumor Promotion via Injury- and Death-Induced Inflammation
Yibin Kang, Klaus Pantel  Cancer Cell 
Stem Cells and Cancer: Two Faces of Eve
Vicki Plaks, Niwen Kong, Zena Werb  Cell Stem Cell 
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
The Dual Role of Bone Morphogenetic Proteins in Cancer
Pathogenesis of idiopathic pulmonary fibrosis (IPF).
Aida Di Gregorio, Sarah Bowling, Tristan Argeo Rodriguez 
Oncogenic ALK signaling.
Genetic Damage and Mutation
Presentation and progression of glioblastoma with PNET features in an adult patient. Presentation and progression of glioblastoma with PNET features in.
If one assumes that spontaneous mutations can occur with approximately each 20 cell divisions (about 1 million cells), and assuming that mutations provide.
Tumor microenvironment features that affect metastatic progression.
Regulating the Cell Cycle
Immunity, Inflammation, and Cancer
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B. Baylin  Molecular Cell 
Mechanical forces can promote tumor aggression.
Biomechanical force may promote tumor progression by establishing an aggressive tumor cell hierarchy. Biomechanical force may promote tumor progression.
Tic-TACs: Refreshing Hair Growth
Illustration of cancer cells and tumor microenvironment–deregulated miRNA target networks leading to tumor growth and progression. Illustration of cancer.
Heterogeneity origins and maintenance.
p53 loss affects several steps of the metastatic process.
Heterozygous Pik3caH1047R oncogenic mutation causes invasive prostate cancer in mice that does not phenocopy Pten deletion. Heterozygous Pik3caH1047R oncogenic.
CD36 expression in tissue adjacent and distal to the tumor.
Presentation transcript:

Corrupted tensional homeostasis accompanies tumor progression. Corrupted tensional homeostasis accompanies tumor progression. The tensional balance required for the proper organization and function of adult tissues can be perturbed by oncogenic mutations that modify mechanosensitive signaling in cells (path going left). Alternatively, oncogenic mutations may be preceded by an increase in tissue mechanics that results from chronic fibrosis or injury (path going right). Cells are in a dynamic mechanoreciprocity with their environment such that newly transformed cells can remodel the extracellular matrix which will feed back and further stimulate mechanosignaling in the tumor cells and surrounding stromal cells. This vicious feed-forward mechanism feeds into and promotes tumor evolution until a new tensional homeostasis is established in the tumor. This process may favor the growth, survival, and expansion or trans-differentiation of stem-like tumor cells that are typically more aggressive given that they frequently display an enhanced survival phenotype and a predisposition to disseminate. Jason J. Northey et al. Cancer Discov 2017;7:1224-1237 ©2017 by American Association for Cancer Research